Clinical trial for Alzheimer Disease and Related Dementias
Official title Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
ClinicalTrials.gov ID: NCT06821568
What this study is testing
- What it's testing
- The study aims to find out whether daily home‑based transcranial direct current stimulation (tDCS) improves thinking skills and walking while multitasking in people with motoric cognitive risk syndrome.
- Who it's for
- Older adults who have motoric cognitive risk syndrome, a condition linking slower walking with early memory problems.
- What's involved
- Participants will use a small tDCS device at home that gently stimulates the left front‑side of the brain, following a personalized schedule, and will attend periodic clinic visits for cognitive and mobility tests.
- Time commitment
- The trial lasts about 6 months, with regular home stimulation sessions and several in‑person visits for assessments.
This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 90
You may be able to join if
- Men and women
- Age 65-90 years
- Subjective cognitive complaints as defined by a 'Yes' response to "Do you feel that you have more problems with memory than most?" or a 'No' response...
- Montreal Cognitive Assessment (MoCA) score ≥21
- Slow gait speed as measured by averaging two 4-Meter walks and defined as a usual walking speed one standard deviation below age and sex-adjusted...
You likely can't join if
- Formal education less than the 8th grade
- Previous physician diagnosis of dementia
- Any current diagnosis of a major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depressive disorder)
- Evidence of moderate-to-severe depressive symptoms defined by a score of ≥9 on the 15-item Geriatric Depression Scale
- History of head trauma resulting in prolonged loss of consciousness
- History of fainting spells of unknown or undetermined etiology that might constitute seizures
See the full eligibility criteria
- Men and women
- Age 65-90 years
- Subjective cognitive complaints as defined by a 'Yes' response to "Do you feel that you have more problems with memory than most?" or a 'No' response to "is your mind as clear as it used to be?"
- Montreal Cognitive Assessment (MoCA) score ≥21
- Slow gait speed as measured by averaging two 4-Meter walks and defined as a usual walking speed one standard deviation below age and sex-adjusted means.
- Absence of significant disability as defined by the ability to walk over the instrumented gait mat unassisted (e.g., able to walk without any walking aids for at least 2 minutes non-stop) and preserved activities of...
- Identification of an eligible informant
- Identification of a willing and able tDCS-administrator; i.e., a study partner to lead the administration of home-based transcranial direct current stimulation (tDCS)
- Access to reliable WiFi in the participant's home
- Formal education less than the 8th grade
- Previous physician diagnosis of dementia
- Any current diagnosis of a major psychiatric disorder (e.g., schizophrenia, bipolar disorder, major depressive disorder)
- Evidence of moderate-to-severe depressive symptoms defined by a score of ≥9 on the 15-item Geriatric Depression Scale
- History of head trauma resulting in prolonged loss of consciousness
- History of fainting spells of unknown or undetermined etiology that might constitute seizures
- History of seizures, diagnosis of epilepsy, or immediate (first-degree relative) family history of epilepsy except for a single seizure of benign etiology (e.g.
- Hospitalization within the past three months due to acute illness, or as the result of a musculoskeletal injury significantly affecting gait or balance
- Any unstable medical condition or chronic (particularly) uncontrolled medical conditions that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.) or...
- Substance use disorders within the past six months
- A hairstyle or headdress that prevents electrode contact with the scalp or would interfere with the stimulation (for example thick braids, hair weave, afro, wig)
- Chronic vertigo
- Myocardial infarction within the past 6 months
- Active cancer for which chemo-/radiation therapy is being received
- Legal blindness
- Visual hallucinations (history or self-report)
- Pacemaker
- Contraindications to MRI or tDCS, including unprovoked seizure within the past two years, risk of ferromagnetic objects anywhere in the body, self-reported presence of specific implanted medical devices (e.g., deep...
- History of REM sleep behavior disorder (RBD), often an early sign of Parkinson's disease
- Medications and medical history will be reviewed by the responsible covering physician and a decision about inclusion will be made based on the participant's past medical history, drug dose, history of recent medication...
The study team makes the final eligibility decision.
Where it is enrolling
- Roslindale, Massachusetts, United States
- Tel Aviv, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Roslindale, Massachusetts, United States; Tel Aviv, Israel. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.